Pharmacopeia Announces New Promotions, Splits COO Position | GenomeWeb

NEW YORK, Feb 13 – Bioinformatics tool provider Pharmacopeia said Tuesday it had promoted Michael Stapleton to the position of chief operating officer for the company’s software division and Stephen Spearman to the position of chief operating officer for the company’s drug discovery business.

The Princeton, NJ-based company decided to create two COO positions for the different divisions following the resignation of Saiid Zarrabian in December.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.